Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC

NCT02824952 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer, Non-small Cell

Interventions

DRUG: Tagrisso

Sponsor

Shaare Zedek Medical Center

Collaborators

[object Object]